Metformin Hydrochloride Oral Solution
NDC Package 71656-017-04
Package Information
Metformin Hydrochloride Oral Solution (metformin hydrochloride) solution is metformin hydrochloride oral solutionĀ is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. This formulation utilizes a solution delivery system. Marketed by Saptalis Pharmaceuticals, Llc., this product is identified by NDC 71656-017 and is authorized under FDA application ANDA211309.
Identification & Billing
- RxCUI: 861025 - metFORMIN HCl 500 MG in 5 mL Oral Solution
- RxCUI: 861025 - metformin hydrochloride 100 MG/ML Oral Solution
- RxCUI: 861025 - metformin hydrochloride 500 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71656 - Saptalis Pharmaceuticals, Llc.
- 71656-017 - Metformin Hydrochloride Oral Solution
- 71656-017-04 - 118 mL in 1 BOTTLE
- 71656-017 - Metformin Hydrochloride Oral Solution
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71656-017-04 identifies a specific commercial package of 118 ml in 1 bottle of Metformin Hydrochloride Oral Solution, a human prescription drug labeled by Saptalis Pharmaceuticals, Llc.. This product is billed per "ML" milliliter and contains an estimated amount of 118 billable units per package. This solution is formulated for oral use and contains metformin hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Saptalis Pharmaceuticals, Llc. on July 31, 2024. The current certification is valid through December 31, 2026.
How is this Saptalis Pharmaceuticals, Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71656001704. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 118 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.